Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 9 member B1 pseudogene 1 (SLC9B1P1) is classified as a pseudogene in the human genome. It is predicted to encode a putative SLC9B1-like protein that may have had antiporter activity, involved in inorganic cation (likely sodium/proton) transmembrane transport, and is predicted to localize to the membrane. However, as a pseudogene, it is not generally believed to produce a functional protein product. There are no established biological functions, disease associations, documented drug interactions, or roles as biomarkers or therapeutic targets currently attributed to SLC9B1P1[1][2][10][12][14][15].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 9 member B1 pseudogene 1 (SLC9B1P1).